GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » PensionAndRetirementBenefit

Curocell (XKRX:372320) PensionAndRetirementBenefit : ₩645.80 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell PensionAndRetirementBenefit?

Curocell's PensionAndRetirementBenefit for the quarter that ended in Jun. 2023 was ₩645.80 Mil.

Curocell's quarterly PensionAndRetirementBenefit increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩391.63 Mil) and increased from Dec. 2022 (₩391.63 Mil) to Jun. 2023 (₩645.80 Mil).

Curocell's annual PensionAndRetirementBenefit declined from Dec. 2021 (₩565.78 Mil) to Dec. 2022 (₩391.63 Mil) but then increased from Dec. 2022 (₩391.63 Mil) to Dec. 2023 (₩431.16 Mil).


Curocell PensionAndRetirementBenefit Historical Data

The historical data trend for Curocell's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell PensionAndRetirementBenefit Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
262.01 531.03 565.78 391.63 431.16

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
PensionAndRetirementBenefit - 391.63 645.80 431.16

Curocell PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines